(Q84512177)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733283%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

D-serine adjuvant treatment alleviates behavioural and motor symptoms in Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733283%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

1 reference

Evgenia Gelfin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733283%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Yakir Kaufman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733283%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Isabelle Korn-Lubetzki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733283%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Boaz Bloch

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733283%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Ilana Kremer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733283%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Daniel C Javitt

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733283%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Uriel Heresco-Levy

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733283%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

7 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733283%20AND%20SRC:MED&resulttype=core&format=json

The International Journal of Neuropsychopharmacology

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733283%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733283%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733283%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

543-549

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733283%20AND%20SRC:MED&resulttype=core&format=json

Pathoanatomy of Parkinson's disease

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001015

7 January 2021

Direct and indirect presynaptic control of dopamine release by excitatory amino acids

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001015

7 January 2021

Rationale for and use of NMDA receptor antagonists in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001015

7 January 2021

High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001015

7 January 2021

D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001015

7 January 2021

Parkinsonism: onset, progression, and mortality

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001015

7 January 2021

Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001015

7 January 2021

Glutamate receptors as therapeutic targets for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001015

7 January 2021

High dose D-serine in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001015

7 January 2021

D-Serine as a putative glial neurotransmitter

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001015

7 January 2021

Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: intrastriatal microinjection studies in the 6-OHDA-lesioned rat.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001015

7 January 2021

NR2B selective NMDA receptor antagonists

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001015

7 January 2021

Apathy in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001015

7 January 2021

Effects of the partial glycine agonist D-cycloserine on cognitive functioning in chronic low dose MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001015

7 January 2021

D-serine is the dominant endogenous coagonist for NMDA receptor neurotoxicity in organotypic hippocampal slices.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001015

7 January 2021

Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001015

7 January 2021

https://api.crossref.org/works/10.1017%2FS1461145711001015

1 reference

7 January 2021

Centrally-administered glycine antagonists increase locomotion in monoamine-depleted mice

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001015

7 January 2021

10.1017/S1461145711001015

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733283%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference